Ability Biologics
Patricia Giblin, with a Ph.D. in Immunology from Yale University, brings a wealth of experience to their current role as Senior Vice President Research at Ability Biologics. Prior to this, Patricia held positions at Revitope, Northern Biologics, and Boehringer Ingelheim Pharmaceuticals, Inc. Their extensive career in the field of biology and scientific research speaks to their expertise and leadership abilities.
This person is not in any teams
This person is not in any offices
Ability Biologics
1 followers
Our Mission: Develop innovative, targeted, immune modulating biotherapeutics to address unmet medical needs in patients with cancer and autoimmune diseases. The premier biotherapeutic targeting company Our powerful AbiLeap™ discovery engine combines massively parallel, continuously learning AI with an extensive database of antigen-antibody interactions to generate fully human, IgG-based multispecific antibodies of exquisite selectivity and affinity. The antibodies respond to environmental signals within the cellular microenvironment, generating logic-gated therapeutics. We are dedicated to developing the most potent and selective antibody therapeutics for areas of great unmet need.